Brief: Starpharma Says Implemented Changes Expected To Reduce Fixed Costs By A$2M By FY25
22/05/2024 02:29
May 22 (Reuters) - Starpharma Holdings Ltd SPL.AX :
* IMPLEMENTED CHANGES EXPECTED TO REDUCE FIXED COSTS BY A$2M
BY
FY25
Further company coverage: SPL.AX
((Reuters.Briefs@thomsonreuters.com;;))
Recent news on Starpharma Holdings
See all newsBrief: Starpharma Increases Stake In Petalion To 66% Securing Majority Ownership
Brief: Starpharma Seeks Trading Halt
Brief: Starpharma Holdings Appoints Russell Basser As Chair
Brief: Starpharma Says Fully Underwritten Entitlement Offer To Raise A$32 MLN
Australia's Starpharma slumps to 1-1/2-month low on discounted fund raising